0 206

Cited 9 times in

Inhibition of EphA2/EphrinA1 signal attenuates lipopolysaccharide-induced lung injury

Authors
 Ji Young Hong  ;  Mi Hwa Shin  ;  Ivor S. Douglas  ;  Kyung Soo Chung  ;  Eun Young Kim  ;  Ji Ye Jung  ;  Young Ae Kang  ;  Se Kyu Kim  ;  Joon Chang  ;  Young Sam Kim  ;  Moo Suk Park 
Citation
 CLINICAL SCIENCE, Vol.130(21) : 1993-2003, 2016 
Journal Title
 CLINICAL SCIENCE 
ISSN
 0143-5221 
Issue Date
2016
MeSH
Animals ; Bronchoalveolar Lavage Fluid/chemistry ; Ephrin-A1/metabolism* ; Humans ; Lipopolysaccharides/adverse effects* ; Lung/metabolism ; Lung Injury/genetics ; Lung Injury/metabolism* ; Male ; Mice ; Mice, Inbred C57BL ; Receptor, EphA2/antagonists & inhibitors ; Receptor, EphA2/genetics ; Receptor, EphA2/metabolism* ; Signal Transduction
Keywords
EphA2 ; EphrinA1 ; acute lung injury ; lipopolysaccharide
Abstract
Eph-Ephrin signalling mediates various cellular processes, including vasculogenesis, angiogenesis, cell migration, axon guidance, fluid homoeostasis and repair after injury. Although previous studies have demonstrated that stimulation of the EphA receptor induces increased vascular permeability and inflammatory response in lung injury, the detailed mechanisms of EphA2 signalling are unknown. In the present study, we evaluated the role of EphA2 signalling in mice with lipopolysaccharide (LPS)-induced lung injury. Acute LPS exposure significantly up-regulated EphA2 and EphrinA1 expression. Compared with LPS+IgG mice (IgG instillation after LPS exposure), LPS+EphA2 mAb mice [EphA2 monoclonal antibody (mAb) instillation posttreatment after LPS exposure] had attenuated lung injury and reduced cell counts and protein concentration of bronchoalveolar lavage fluid (BALF). EphA2 mAb posttreatment down-regulated the expression of phosphoinositide 3-kinases (PI3K) 110γ, phospho-Akt, phospho-NF-κB p65, phospho-Src and phospho-S6K in lung lysates. In addition, inhibiting the EphA2 receptor augmented the expression of E-cadherin, which is involved in cell-cell adhesion. Our study identified EphA2 receptor as an unrecognized modulator of several signalling pathways-including PI3K-Akt-NF-kB, Src-NF-κB, E-cadherin and mTOR-in LPS-induced lung injury. These results suggest that EphA2 receptor inhibitors may function as novel therapeutic agents for LPS-induced lung injury.
Full Text
http://www.clinsci.org/content/130/21/1993
DOI
10.1042/CS20160360
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Internal Medicine (내과학교실) > 1. Journal Papers
Yonsei Authors
Kang, Young Ae(강영애) ORCID logo https://orcid.org/0000-0002-7783-5271
Kim, Se Kyu(김세규)
Kim, Young Sam(김영삼) ORCID logo https://orcid.org/0000-0001-9656-8482
Kim, Eun Young(김은영) ORCID logo https://orcid.org/0000-0002-3281-5744
Park, Moo Suk(박무석) ORCID logo https://orcid.org/0000-0003-0820-7615
Chang, Joon(장준) ORCID logo https://orcid.org/0000-0003-4542-6841
Jung, Kyung Soo(정경수) ORCID logo https://orcid.org/0000-0003-1604-8730
Jung, Ji Ye(정지예) ORCID logo https://orcid.org/0000-0003-1589-4142
URI
https://ir.ymlib.yonsei.ac.kr/handle/22282913/152254
사서에게 알리기
  feedback

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse